Literature DB >> 16036240

Determinants of HAART discontinuation among injection drug users.

T Kerr1, A Marshall, J Walsh, A Palepu, M Tyndall, J Montaner, R Hogg, E Wood.   

Abstract

The objective of this study was to identify psychosocial determinants of, and self-reported reasons for, HAART discontinuation among HIV-positive injection drug users (IDUs). We examined correlates between sociodemographic characteristics, drug use and risk behaviors, outcome expectations, adherence self-efficacy, social support and HAART discontinuation among 160 HIV-positive participants in the Vancouver Injection Drug Users' Study (VIDUS). Logistic regression was used to identify the factors independently associated with discontinuation of HAART. Seventy-one (44%) study participants discontinued HAART during the study period. Factors independently associated with discontinuation of HAART included recent incarceration (OR = 4.84, p = 0.022), negative outcome expectations (OR = 1.41, p = 0.001), adherence efficacy expectations (OR = 0.70, p = 0.003) and self-regulatory efficacy (OR = 0.86, p = 0.050). The most frequently cited reasons provided for discontinuing HAART were being in jail (44%) and medication side effects (41%). The results of this study suggest that psychological constructs derived from self-efficacy theory are highly germane to the understanding of HAART discontinuation behavior and interventions that may change it. Incarceration may result in interruptions in HAART among IDUs, and programmatic changes may be needed to promote optimal retention on HAART among incarcerated HIV-infected IDUs.

Entities:  

Mesh:

Year:  2005        PMID: 16036240     DOI: 10.1080/09540120412331319778

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  46 in total

1.  Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco.

Authors:  Parya Saberi; Nikolai H Caswell; Ross Jamison; Milton Estes; Jacqueline P Tulsky
Journal:  J Urban Health       Date:  2012-10       Impact factor: 3.671

2.  Offer of financial incentives for unprotected sex in the context of sex work.

Authors:  Caitlin L Johnston; Cody Callon; Kathy Li; Evan Wood; Thomas Kerr
Journal:  Drug Alcohol Rev       Date:  2010-03

3.  The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs.

Authors:  Kora DeBeck; Thomas Kerr; Calvin Lai; Jane Buxton; Julio Montaner; Evan Wood
Journal:  Am J Drug Alcohol Abuse       Date:  2011-08-11       Impact factor: 3.829

4.  The HIV Medication Taking Self-efficacy Scale: psychometric evaluation.

Authors:  Judith A Erlen; Eun Seok Cha; Kevin H Kim; Donna Caruthers; Susan M Sereika
Journal:  J Adv Nurs       Date:  2010-08-16       Impact factor: 3.187

5.  Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative.

Authors:  Ryan McNeil; Thomas Kerr; Bill Coleman; Lisa Maher; M J Milloy; Will Small
Journal:  AIDS Behav       Date:  2017-02

6.  Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States.

Authors:  Alison J Hughes; Christine L Mattson; Susan Scheer; Linda Beer; Jacek Skarbinski
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

7.  Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.

Authors:  Venkatesan Chakrapani; Jaikumar Velayudham; Murali Shunmugam; Peter A Newman; Robert Dubrow
Journal:  AIDS Care       Date:  2013-11-28

Review 8.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

Review 9.  HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care.

Authors:  Ryan P Westergaard; Anne C Spaulding; Timothy P Flanigan
Journal:  Curr Opin Infect Dis       Date:  2013-02       Impact factor: 4.915

10.  Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.

Authors:  Bianca Yeung; N A Mohd Salleh; Eugenia Socías; Huiru Dong; J Shoveller; J S G Montaner; M-J S Milloy
Journal:  AIDS Behav       Date:  2019-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.